Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 3
2010 5
2011 3
2012 7
2013 12
2014 21
2015 20
2016 26
2017 25
2018 22
2019 27
2020 40
2021 36
2022 46
2023 45
2024 14

Text availability

Article attribute

Article type

Publication date

Search Results

298 results

Results by year

Filters applied: . Clear all
Page 1
ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D. Ramiro S, et al. Ann Rheum Dis. 2023 Jan;82(1):19-34. doi: 10.1136/ard-2022-223296. Epub 2022 Oct 21. Ann Rheum Dis. 2023. PMID: 36270658 Free article.
OBJECTIVES: To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of axial spondyloarthritis (axSpA). ...Recommendations 6-8 deal with analgesics and discourage long-term glucocorticoids and conven …
OBJECTIVES: To update the Assessment of SpondyloArthritis international Society (ASAS)-EULAR recommendations for the management of …
Treatment of axial spondyloarthritis: an update.
Danve A, Deodhar A. Danve A, et al. Nat Rev Rheumatol. 2022 Apr;18(4):205-216. doi: 10.1038/s41584-022-00761-z. Epub 2022 Mar 10. Nat Rev Rheumatol. 2022. PMID: 35273385 Review.
Diagnosis and management of axial spondyloarthritis (axSpA) has vastly improved over the past two decades. With advances in the discernment of immunopathogenesis of this disease, new therapies have become available, which are associated with substantial impro …
Diagnosis and management of axial spondyloarthritis (axSpA) has vastly improved over the past two decades. With advances in th …
Axial spondyloarthritis: new advances in diagnosis and management.
Ritchlin C, Adamopoulos IE. Ritchlin C, et al. BMJ. 2021 Jan 4;372:m4447. doi: 10.1136/bmj.m4447. BMJ. 2021. PMID: 33397652 Review.
Axial spondyloarthritis (axSpA) is an inflammatory disease of the axial skeleton associated with significant pain and disability. ...
Axial spondyloarthritis (axSpA) is an inflammatory disease of the axial skeleton associated with significant pain and d …
Recognizing Axial Spondyloarthritis: A Guide for Primary Care.
Magrey MN, Danve AS, Ermann J, Walsh JA. Magrey MN, et al. Mayo Clin Proc. 2020 Nov;95(11):2499-2508. doi: 10.1016/j.mayocp.2020.02.007. Epub 2020 Jul 29. Mayo Clin Proc. 2020. PMID: 32736944 Free article. Review.
Axial spondyloarthritis (axSpA) is an important cause of chronic low back pain and affects approximately 1% of the US population. ...Individual searches were performed to identify potential articles of interest related to axSpA (search terms: ["axSpA" OR "axial …
Axial spondyloarthritis (axSpA) is an important cause of chronic low back pain and affects approximately 1% of the US populati …
2019 Update of the American College of Rheumatology/Spondylitis Association of America/Spondyloarthritis Research and Treatment Network Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis.
Ward MM, Deodhar A, Gensler LS, Dubreuil M, Yu D, Khan MA, Haroon N, Borenstein D, Wang R, Biehl A, Fang MA, Louie G, Majithia V, Ng B, Bigham R, Pianin M, Shah AA, Sullivan N, Turgunbaev M, Oristaglio J, Turner A, Maksymowych WP, Caplan L. Ward MM, et al. Arthritis Care Res (Hoboken). 2019 Oct;71(10):1285-1299. doi: 10.1002/acr.24025. Epub 2019 Aug 21. Arthritis Care Res (Hoboken). 2019. PMID: 31436026 Free PMC article. Review.
OBJECTIVE: To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic axial spondyloarthritis (SpA). METHODS: We conducted updated systematic literature reviews for 20 clinical questions on pharmacolog …
OBJECTIVE: To update evidence-based recommendations for the treatment of patients with ankylosing spondylitis (AS) and nonradiographic ax …
Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J, Kiltz U, Baraliakos X. Braun J, et al. Drug Des Devel Ther. 2022 Oct 19;16:3609-3620. doi: 10.2147/DDDT.S330413. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36268520 Free PMC article. Review.
Although the pathogenesis of spondyloarthritis (SpA) has still not been elucidated our options to treat SpA have definitely improved in the last decades. There are two main types of SpA: (i) axial spondyloarthritis (axSpA), also covering the classical ankylos …
Although the pathogenesis of spondyloarthritis (SpA) has still not been elucidated our options to treat SpA have definitely improved …
Efficacy and safety of biological DMARDs: a systematic literature review informing the 2022 update of the ASAS-EULAR recommendations for the management of axial spondyloarthritis.
Webers C, Ortolan A, Sepriano A, Falzon L, Baraliakos X, Landewé RBM, Ramiro S, van der Heijde D, Nikiphorou E. Webers C, et al. Ann Rheum Dis. 2023 Jan;82(1):130-141. doi: 10.1136/ard-2022-223298. Epub 2022 Oct 21. Ann Rheum Dis. 2023. PMID: 36270657 Review.
OBJECTIVE: To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2022 update of the Assessment of SpondyloArthritis international Society/Euro …
OBJECTIVE: To update the evidence on efficacy and safety of biological disease-modifying antirheumatic drugs (bDMARDs) in patients with a …
Imaging of axial spondyloarthritis. New aspects and differential diagnoses.
Braun J, Baraliakos X, Buehring B, Kiltz U, Fruth M. Braun J, et al. Clin Exp Rheumatol. 2018 Sep-Oct;36 Suppl 114(5):35-42. Epub 2018 Oct 1. Clin Exp Rheumatol. 2018. PMID: 30296971 Free article. Review.
Axial spondyloarthritis (axSpA) is a chronic rheumatic disease characterised by inflammatory back pain and several other disease manifestations and comorbidities. ...Importantly, back pain in patients with axSpA may well have reasons other than axial inflamma …
Axial spondyloarthritis (axSpA) is a chronic rheumatic disease characterised by inflammatory back pain and several other disea …
2016 update of the ASAS-EULAR management recommendations for axial spondyloarthritis.
van der Heijde D, Ramiro S, Landewé R, Baraliakos X, Van den Bosch F, Sepriano A, Regel A, Ciurea A, Dagfinrud H, Dougados M, van Gaalen F, Géher P, van der Horst-Bruinsma I, Inman RD, Jongkees M, Kiltz U, Kvien TK, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compàn V, Ozgocmen S, Pimentel-Santos FM, Reveille J, Rudwaleit M, Sieper J, Sampaio-Barros P, Wiek D, Braun J. van der Heijde D, et al. Ann Rheum Dis. 2017 Jun;76(6):978-991. doi: 10.1136/annrheumdis-2016-210770. Epub 2017 Jan 13. Ann Rheum Dis. 2017. PMID: 28087505 Free article. Review.
To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibitors (TNFi) in axial spondyloarthritis (axSpA) into one set applicable to the full spectrum of patients with axSpA. ...The fina …
To update and integrate the recommendations for ankylosing spondylitis and the recommendations for the use of tumour necrosis factor inhibit …
Diagnostic triage for low back pain: a practical approach for primary care.
Bardin LD, King P, Maher CG. Bardin LD, et al. Med J Aust. 2017 Apr 3;206(6):268-273. doi: 10.5694/mja16.00828. Med J Aust. 2017. PMID: 28359011 Review.
For specific spinal pathologies (eg, vertebral fracture, malignancy, infection, axial spondyloarthritis or cauda equina syndrome), a clinical assessment may reveal the key alerting features. ...A diagnosis of NSLBP presumes exclusion of specific pathologies and nerv …
For specific spinal pathologies (eg, vertebral fracture, malignancy, infection, axial spondyloarthritis or cauda equina syndro …
298 results